Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis

D Adeloye, P Song, Y Zhu, H Campbell… - The Lancet …, 2022 - thelancet.com
Background Chronic obstructive pulmonary disease (COPD) is an increasingly important
cause of morbidity, disability, and mortality worldwide. We aimed to estimate global …

Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment

IA Yang, CR Jenkins, SS Salvi - The Lancet Respiratory Medicine, 2022 - thelancet.com
Chronic obstructive pulmonary disease (COPD) was traditionally thought to be caused by
tobacco smoking. However, recognition of the importance of non-smoking-related risk …

Improving lung health in low-income and middle-income countries: from challenges to solutions

J Meghji, K Mortimer, A Agusti, BW Allwood, I Asher… - The Lancet, 2021 - thelancet.com
Low-income and middle-income countries (LMICs) bear a disproportionately high burden of
the global morbidity and mortality caused by chronic respiratory diseases (CRDs), including …

Association of clonal hematopoiesis with chronic obstructive pulmonary disease

PG Miller, D Qiao, J Rojas-Quintero… - Blood, The Journal …, 2022 - ashpublications.org
Chronic obstructive pulmonary disease (COPD) is associated with age and smoking, but
other determinants of the disease are incompletely understood. Clonal hematopoiesis of …

Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study

C Wang, J Xu, L Yang, Y Xu, X Zhang, C Bai, J Kang… - The Lancet, 2018 - thelancet.com
Background Although exposure to cigarette smoking and air pollution is common, the
current prevalence of chronic obstructive pulmonary disease (COPD) is unknown in the …

[HTML][HTML] Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and …

GBD 2015 Chronic Respiratory Disease … - The Lancet …, 2017 - ncbi.nlm.nih.gov
Background Chronic obstructive pulmonary disease (COPD) and asthma are common
diseases with a heterogeneous distribution worldwide. Here, we present methods and …

Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary

CF Vogelmeier, GJ Criner, FJ Martinez… - American journal of …, 2017 - atsjournals.org
This Executive Summary of the Global Strategy for the Diagnosis, Management, and
Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 …

[HTML][HTML] Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and …

JB Soriano, AA Abajobir, KH Abate… - The Lancet …, 2017 - thelancet.com
Background Chronic obstructive pulmonary disease (COPD) and asthma are common
diseases with a heterogeneous distribution worldwide. Here, we present methods and …

Chronic obstructive pulmonary disease in China: a nationwide prevalence study

L Fang, P Gao, H Bao, X Tang, B Wang… - The Lancet …, 2018 - thelancet.com
Background Because of the rapid change in economic development and lifestyle in China,
and the ageing population, concerns have grown that chronic obstructive pulmonary …

[HTML][HTML] Global and regional estimates of COPD prevalence: Systematic review and meta–analysis

D Adeloye, S Chua, C Lee, C Basquill… - Journal of global …, 2015 - ncbi.nlm.nih.gov
Background The burden of chronic obstructive pulmonary disease (COPD) across many
world regions is high. We aim to estimate COPD prevalence and number of disease cases …